Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus propofol for early cognitive function after painless endoscopic therapy
ChiCTR1900022639Phase 4Completed
- Sponsor
- The First Affiliated Hospital of Wenzhou Medical University
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexmedetomidine and propofol (5 arms), sponsored by The First Affiliated Hospital of Wenzhou Medical University. Primary endpoint: Cognitive function. Started May 2019; status: completed.
02
Drugs
dexmedetomidinepropofol
Beyond the preview
Go deeper on ChiCTR1900022639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900022639.